Let our precision and consistency advance your science!
We take full responsibility for every step of our projects: from contracting with the biobanks and clinical sites, applying for ethical approvals, training lab personnel on non-clinical sample processing protocols, storage and logistics. We are committed to help our pharma clients to advance discovery and development of new therapeutics and diagnostic kits in any field of medicine.
Challenge us with your studies!
We are a professional and enthusiastic team of biomedical scientists and medical doctors with experience in establishing biobanking projects and customized pre-clinical biospecimen collection studies. Our transparent business model enables us to bridge between our pharma clients and biobanking partners to conduct direct discussions around technical, medical and scientific aspects of patient cohorts’ selection, biospecimen collections, and processing protocols.
ART-Biopharma adheres to the highest standards of ethics and conducts pre-clinical studies with deepest respect and gratitude towards the patients (regardless of their readiness to donate biospecimens) and clinicians participating in our projects. Professional approach and ethical norms are of paramount importance to us!
ART-Biopharma is working with biobanking sites locally in Armenia and worldwide: our network of partners include such establishments as academia-affiliated hospitals, private and state-owned clinical sites, bone fide biobanks, diagnostic reference laboratories, and individual clinical investigators. All our local and international clinical and biobanking partners operate under valid External or Internal Research Board (IRB) or Ethics Committee (EC) approvals. All prospectively-collected samples are included in our studies exclusively under patients’ informed consent (i.e. upon ICF signature) avidly adhering to the statutes of the Helsinki Declaration, which was developed by The World Medical Association (WMA) as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data. If applicable, archival samples may be provided under IRB-approved waiver of consent, however, the consent status is always communicated to the pharma End Users.
Since ART-Biopharma cooperates with biospecimen providers worldwide, we are compliant with local, regional and international regulations and relevant legislatures (e.g. including HIPAA, PIPEDA, GDPR, and country-specific laws and regulations).
Have questions or interested in our services?
Please send us a message and we’ll get back to you shortly